Sari Izenwasser

Dr. Sari Izenwasser


Research Focus & Metrics

Academic Career Length

41Years (1986-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 April 2002 in Journal of Neurochemistry
Verified
Journal Article
Open access
PDF file
DMDeborah C. Mash
Deborah C. Mash
JPJohn Pablo
John Pablo
QOQinjie Ouyang
Qinjie Ouyang
WHW. Lee Hearn
W. Lee Hearn
SISari Izenwasser
Sari Izenwasser
Dopaminergic transmission has been suggested to be a primary mechanism mediating reinforcement, withdrawal and craving associated with psychostimulant addiction. Pyschostimulants attenuate dopamine transporter (DAT) clearance efficiency, resulting in a net increase in synaptic dopamine levels. Re‐uptake rate is determined by the number of functional DAT molecules at the membrane surface. Previousin vivoimaging studies in humans andin vitrostudies in post‐mortem human brain have demonstrated that chronic cocaine abuse results in a neuroadaptive increase in DAT‐binding site density in the limbic striatum. Whether this increase in DAT availability represents an increase in the functional activity of the transporter is unknown. Here, we present evidence that DAT function is elevated by chronic cocaine abuse. The effect of increasing post‐mortem interval on the functional viability of synaptosomes was modeled in the baboon brain. Baboon brains sampled under conditions similar to human brain autopsies yielded synaptosomal preparations that were viable up to 24 h post‐mortem. Dopamine (DA) uptake was elevated twofold in the ventral striatum from cocaine users as compared to age‐matched drug‐free control subjects. The levels of [3H]DA uptake were not elevated in victims of excited cocaine delirium, who experienced paranoia and marked agitation prior to death. In keeping with the increase in DAT function, [3H]WIN 35,428 binding was increased in the cocaine users, but not in the victims of excited delirium. These results demonstrate that DA uptake function assayed in cryopreserved human brain synaptosomes is a suitable approach for testing hypotheses of the mechanisms underlying human brain disorders and for studying the actions of addictive drugs in man.

1 March 2004 in Neuropharmacology
Verified
Journal Article
Closed access
SCStephanie L Collins
Stephanie L Collins
SISari Izenwasser
Sari Izenwasser

1 March 2009 in Pharmacology Biochemistry and Behavior
Verified
Journal Article
Closed access
EZElena Zakharova
Elena Zakharova
DWDean Wade
Dean Wade
SISari Izenwasser
Sari Izenwasser

1 March 2009 in Behavioural Brain Research
Verified
Journal Article
Closed access
EZElena Zakharova
Elena Zakharova
GLGiorgia Leoni
Giorgia Leoni
IKIlona Kichko
Ilona Kichko
SISari Izenwasser
Sari Izenwasser

1 April 2003 in The Journal of Neuroscience
Verified
Journal Article
Closed access
PDF file
DMDeborah C. Mash
Deborah C. Mash
QOQinjie Ouyang
Qinjie Ouyang
JPJohn Pablo
John Pablo
MBMargaret Basile
Margaret Basile
SISari Izenwasser
Sari Izenwasser
RPRichard J. Perrin
Richard J. Perrin
α-Synuclein is a presynaptic protein that has been implicated as a possible causative agent in the pathogenesis of Parkinson's disease. The native protein is a major component of nigral Lewy bodies in Parkinson's disease, and full-length α-synuclein accumulates in Lewy neurites. Here we present evidence that α-synuclein levels are elevated in midbrain dopamine (DA) neurons of chronic cocaine abusers. Western blot and immunoautoradiographic studies were conducted on postmortem neuropathological specimens from cocaine users and age-matched drug-free control subjects. The results demonstrated that α-synuclein levels in the DA cell groups of the substantia nigra/ventral tegmental complex were elevated threefold in chronic cocaine users compared with normal age-matched subjects. The increased protein levels in chronic cocaine users were accompanied by changes in the expression of α-synuclein mRNA in the substantia nigra and ventral tegmental area. Although α-synuclein expression is prominent in the hippocampus, there was no increase in protein expression in this brain region. The levels of β-synuclein, a possible negative regulator of α-synuclein, also were not affected by cocaine exposure. α-Synuclein protein levels were increased in the ventral tegmental area, but not the substantia nigra, in victims of excited cocaine delirium who experienced paranoia, marked agitation, and hyperthermia before death. The overexpression of α-synuclein may occur as a protective response to changes in DA turnover and increased oxidative stress resulting from cocaine abuse. However, the accumulation of α-synuclein protein with long-term cocaine abuse may put addicts at increased risk for developing the motor abnormalities of Parkinson's disease.

1 June 1990 in Brain Research
Verified
Journal Article
Closed access
SISari Izenwasser
Sari Izenwasser
LWLinda L. Werling
Linda L. Werling
BCBrian M. Cox
Brian M. Cox